These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3035078)

  • 21. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.
    Lemon SM; Binn LN
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2501-5. PubMed ID: 2997380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses.
    Hughes JV; Stanton LW
    J Virol; 1985 Aug; 55(2):395-401. PubMed ID: 2991564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus.
    Brack K; Frings W; Dotzauer A; Vallbracht A
    J Virol; 1998 Apr; 72(4):3370-6. PubMed ID: 9525664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cultivation of buffalo green monkey kidney cells persistently infected with hepatitis A virus.
    Chitambar SD; Grewal SM; Bokil M; Srinivasan MA; Banerjee K
    Indian J Med Res; 1994 Mar; 99():115-20. PubMed ID: 8063346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of human and simian hepatitis A virus isolated by an immunoenzyme method using polyclonal and monoclonal antibodies].
    Karetnyĭ IuV; Andzhaparidze AG; Orlova TM; Balaian MS
    Vopr Virusol; 1989; 34(1):50-3. PubMed ID: 2543140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid stability of hepatitis A virus.
    Scholz E; Heinricy U; Flehmig B
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2481-5. PubMed ID: 2550575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Accumulation of the infectious virus and the viral antigen during the multiplication of the hepatitis A virus in an embryonic kidney cell culture of the rhesus macaque (FRhK-4)].
    Kusov IuIu; Fleer GP; Zavodova TI; Panina LI; Donets MA
    Vopr Virusol; 1987; 32(3):307-12. PubMed ID: 2445108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production, quality control and characterization of an inactivated hepatitis A vaccine.
    Peetermans J
    Vaccine; 1992; 10 Suppl 1():S99-101. PubMed ID: 1335671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect.
    Zhang H; Chao SF; Ping LH; Grace K; Clarke B; Lemon SM
    Virology; 1995 Oct; 212(2):686-97. PubMed ID: 7571438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
    Yap KL; Lam SK
    J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the 3A genomic region of two cytopathic strains of hepatitis A virus isolated in Italy.
    Morace G; Pisani G; Beneduce F; Divizia M; Panà A
    Virus Res; 1993 May; 28(2):187-94. PubMed ID: 8391192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on heat inactivation of hepatitis A virus with special reference to shellfish. Part 1. Procedures for infection and recovery of virus from laboratory-maintained cockles.
    Millard J; Appleton H; Parry JV
    Epidemiol Infect; 1987 Jun; 98(3):397-414. PubMed ID: 3036554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of a virus isolated from patients with MS-1 infectious hepatitis.
    Meinick JL; Boucher DW; Craske J; Boggs J
    J Infect Dis; 1971 Jul; 124(1):76-85. PubMed ID: 4335452
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival of hepatitis A virus and poliovirus type 1 in mineral water.
    Biziagos E; Passagot J; Crance JM; Deloince R
    Appl Environ Microbiol; 1988 Nov; 54(11):2705-10. PubMed ID: 2850763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virus.
    Krah DL; Amin RD; Nalin DR; Provost PJ
    J Infect Dis; 1991 Mar; 163(3):634-7. PubMed ID: 1847404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.